Leidos Holdings, Inc. · NYSE:LDOS

Leidos — Q1 2026 Earnings Presentation

13 slides from Leidos's earnings presentation, May 5, 2026

  1. Slide 1: Leidos Q1 FY26 Earnings Conference Call

    LEIDOS Q1 FY26 EARNINGS CONFERENCE CALL May 5, 2026

  2. Slide 2: Forward-Looking Statements

    FORWARD-LOOKING STATEMENTS Certain statements in this release contain or are based on "forward- protests; changes in U.S. government procurement rules, regulations with the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act of 2010 looking" information within the meaning of the Private Securit

  3. Slide 3: Non-GAAP Financial Measures

    NON-GAAP FINANCIAL MEASURES This presentation includes certain non-GAAP financial measures, such as Leidos does not provide a reconciliation of forward-looking adjusted organic growth, non-GAAP operating income, non-GAAP operating EBITDA margins or non-GAAP diluted EPS to GAAP net income, due to the

  4. Slide 4: CEO Highlights

    CEO HIGHLIGHTS STRONG Q1 RESULTS EXECUTION OF NORTHSTAR 2030 IN FULL SWING } YoY revenue up 4%; Q1 adjusted EBITDA 14.0% KEY PROOF POINTS } Raising 2026 guidance for revenue, non-GAAP EPS, and operating cash flow AI IS AN ACCELERANT OF OUR BUSINESS MODEL Investments in Focused, Fast & Lean Leverage

  5. Slide 5: Q1 FY26 Results: Income Statement

    Q1 FY26 RESULTS: INCOME STATEMENT REVENUES (M) ADJUSTED EBITDA MARGIN NON-GAAP DILUTED EPS $4,400 $4,245 $3.13 14.2% 14.0% $2.97 +3.7% -20 bps +5.4% Q1 FY25 Q1 FY26 Q1 FY25 Q1 FY26 Q1 FY25 Q1 FY26 Q1 FY26 EARNINGS CONFERENCE CALL 5

  6. Slide 6: Q1 FY26 Results: Segment View

    Q1 FY26 RESULTS: SEGMENT VIEW INTELLIGENCE & DIGITAL HEALTH HOMELAND DEFENSE $1,513 $1,408 Revenue (M) $1,188 $1,188 $816 $879 $883 $770 +7.5% +—% +6.0% +0.5% Q1 FY25 Q1 FY26 Q1 FY25 Q1 FY26 Q1 FY25 Q1 FY26 Q1 FY25 Q1 FY26 24.7% 24.2% Non-GAAP OI % 9.7% 10.2% 9.8% 9.4% 8.5% 8.3% +50 bps -50 bps -90

  7. Slide 7: Q1 FY26 Results: Cash Flow / Balance Sheet

    Q1 FY26 RESULTS: CASH FLOW / BALANCE SHEET Cash Flow Generation Capital Deployment Balance Sheet Exceptional Q1 cash flows Issued $1.4B in senior notes Healthy balance sheet with driven by strong EBITDA and held $300M in commercial no near-term debt performance, collections, and paper to fund $2.4B

  8. Slide 8: 2026 Guidance

    2026 GUIDANCE MEASURE CURRENT PRIOR Revenues (B) $18.00 - $18.40 $17.50 - $17.90 Adjusted EBITDA Margin Mid 13% Mid 13% Non-GAAP Diluted EPS $12.10 - $12.50 $12.05 - $12.45 Cash Flows Provided by Operating Activities (B) Approximately $1.80 Approximately $1.75 KEY DRIVERS AND ASSUMPTIONS } Raises to

  9. Slide 9: Appendix: Non-GAAP Reconciliations

    APPENDIX NON-GAAP RECONCILIATIONS Q1 FY26 EARNINGS CONFERENCE CALL 9

  10. Slide 10: Organic Growth

    ORGANIC GROWTH (in millions, except growth rates) Q1 FY26 Q1 FY25 % Change Intelligence & Digital Revenues, as reported $ 1,513 $ 1,408 7% Acquisition revenues(1) 22 — Organic revenues 1,491 1,408 6% Health Revenues, as reported 1,188 1,188 —% Homeland Revenues, as reported 816 770 6% Acquisition an

  11. Slide 11: Non-GAAP Income Metrics

    NON-GAAP INCOME METRICS Three Months Ended April 3, 2026 Three Months Ended April 4, 2025 Acquisition, Acquisition, integration Settlement Acquisition integration and Amortization loss on related and Amortization restructuring of acquired pension plan financing Non-GAAP restructuring of acquired Non

  12. Slide 12: Non-GAAP Segment Operating Income

    NON-GAAP SEGMENT OPERATING INCOME Three Months Ended April 3, 2026 Acquisition, integration and Amortization Non-GAAP Non-GAAP Operating restructuring of acquired operating operating (in millions, except margin percentages) income (loss) costs intangibles (1) income (loss) margin(1) Intelligence & D

  13. Slide 13: Non-GAAP Free Cash Flow

    NON-GAAP FREE CASH FLOW Three Months Ended (in millions, except conversion ratio) April 3, 2026 April 4, 2025 Net cash provided by operating activities $ 301 $ 58 Payments for property, equipment and software (31) (22) Non-GAAP free cash flow $ 270 $ 36 Net income attributable to Leidos common stock

Leidos Holdings — Q1 2026 Earnings Presentation on 6ix